Precision driven insights for better patient care, every time
Our mission is to equip patients in Africa and their doctors with vital genetic insights, empowering them to live healthier, longer lives. By providing detailed information, we enable healthcare professionals to make informed treatment decisions tailored to each patient's specific needs.
We offer a range of precision medicine solutions designed to help you deliver the highest quality care to your patients.
Genomic Profiling
We provide comprehensive genomic profiling solutions, including tissue and liquid sample analysis, specialized cancer panels, and advanced next-generation sequencing for both DNA and RNA.
Direct by Sydicate Bio™ Platform
Our Direct platform streamlines test ordering and fulfillment while providing quick access to valuable patient insights.
Actionable Insights
Our tests provide comprehensive and actionable insights into genetic variants, their clinical significance, and implications, empowering doctors to make informed treatment decisions for their patients.
Clinical Studies and Trials
We conduct IRB-approved observational and interventional clinical studies within your institution, providing access to critical insights and life-saving interventions.
Get access to these tests using the Direct by Syndicate BioTM web app
Hereditary cancers
This test analyzes an individual's genome to identify genetic mutations linked to hereditary cancers, including breast, colon, and prostate cancers. Our hereditary cancer tests analyze hundreds of genes, including BRCA1 and BRCA2, ATM, PALB2, TP53, and CHEK1 and CHEK2, among many others, providing comprehensive insights into genetic cancer risks.
Somatic cancers
This test provides in-depth insights into the genetic mutations and variations found in solid and blood tumors, helping your doctor tailor a treatment plan to the specific genetic profile of the tumor. Our somatic cancer tests examine hundreds of genes, including ERBB2 (Her2), TP53, BRAF, EGFR, KRAS, NRAS, ABL1, BRCA1 & BRCA2, JAK1/2/3, and many more, providing comprehensive insights for targeted cancer treatment.
Non-Invasive Prenatal Screening
This test evaluates the likelihood of chromosomal conditions such as trisomy 21 (Down syndrome), trisomy 18 (Edwards syndrome), and trisomy 13 (Patau syndrome), while also determining fetal gender. As a non-invasive procedure, it requires only a simple blood draw and poses no risk to the fetus.
Pharmacogenomics
This test examines how a patient’s genetic profile influences their response to medications. By providing valuable insights, it helps you select the most effective drugs and optimal dosage for your patients, minimizing adverse reactions and enhancing treatment success.
Precision54TM Clinical Hub
Transform your research using the Precision54TM Clinical Hub
Join the Precision54TM Network to access cutting-edge research via our Precision54TM Clinical Hub. Together, we can advance medical studies and deliver life-saving innovations to patients.
